Response variables | Effect | HR estimate (95% CI) | P value |
Presence of SLEDAI-LD | LN group versus no-LN group | 0.503 (0.345 to 0.735) | 0.0004 |
Low-CS | LN group versus no-LN group | 0.600 (0.405 to 0.888) | 0.01 |
Non-white versus white | 0.631 (0.446 to 0.892) | 0.009 | |
Presence of LLDAS | LN group versus no-LN group | 0.547 (0.360 to 0.833) | 0.005 |
Non-white versus white | 0.710 (0.495 to 1.019) | 0.06 | |
Presence of any T2T states | LN group versus no-LN group | 0.647 (0.445 to 0.940) | 0.02 |
CS, corticosteroid; LLDAS, lupus low disease activity state; LN, lupus nephritis; low-CS, limited corticosteroid use; SLEDAI-LD, SLEDAI score of <4; T2T, treat-to-target.